Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$91.6M |
| 2 |
Abbott
ABT
|
+$75M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$74.8M |
| 4 |
JPMorgan Chase
JPM
|
+$69.6M |
| 5 |
Alibaba
BABA
|
+$68.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$96.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$92.4M |
| 3 |
Johnson Controls International
JCI
|
+$76.9M |
| 4 |
Dollar General
DG
|
+$76.8M |
| 5 |
Boston Scientific
BSX
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.75% |
| 2 | Consumer Discretionary | 13.2% |
| 3 | Financials | 11.45% |
| 4 | Industrials | 10.99% |
| 5 | Healthcare | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
CALL
Arcturus Therapeutics
ARCT
$408M
| $1.4M | 0.01% |
+30,000
| New | +$1.03M |
|
777
Casella Waste Systems
CWST
$6.03B
| $1.39M | 0.01% |
+26,711
| New | +$1.27M |
|
778
Automatic Data Processing
ADP
$112B
| $1.39M | 0.01% |
+9,309
| New | +$1.33M |
|
|
PCH
779
DELISTED
PotlatchDeltic
PCH
| $1.38M | 0.01% |
36,346
+17,342
| +91% | +$586K |
|
780
CALL
Chipotle Mexican Grill
CMG
$48.1B
| $1.37M | 0.01% |
+65,000
| New | +$1.2M |
|
|
HBI
781
DELISTED
Hanesbrands
HBI
| $1.37M | 0.01% |
121,073
-215,380
| -64% | -$2.15M |
|
782
PUT
Dropbox
DBX
$7.58B
| $1.36M | 0.01% |
+62,500
| New | +$1.32M |
|
|
GWB
783
DELISTED
Great Western Bancorp, Inc.
GWB
| $1.36M | 0.01% |
+98,926
| New | +$1.57M |
|
|
COHR
784
DELISTED
Coherent Inc
COHR
| $1.35M | 0.01% |
10,275
-115,315
| -92% | -$15.1M |
|
|
TMX
785
DELISTED
Terminix Global Holdings, Inc.
TMX
| $1.32M | 0.01% |
+36,979
| New | +$1.14M |
|
786
CALL
New Oriental
EDU
$8.97B
| $1.3M | 0.01% |
10,000
| – | – |
|
|
LCAHU
787
DELISTED
Landcadia Holdings II, Inc. Unit
LCAHU
| $1.3M | 0.01% |
+75,000
| New | +$789K |
|
788
Bank of Montreal
BMO
$121B
| $1.28M | 0.01% |
24,086
-41,631
| -63% | -$2.12M |
|
789
CALL
Citigroup
C
$221B
| $1.28M | 0.01% |
25,000
-90,000
| -78% | -$4.27M |
|
790
Tenet Healthcare
THC
$22.4B
| $1.25M | 0.01% |
+69,095
| New | +$1.36M |
|
791
Vertex Pharmaceuticals
VRTX
$139B
| $1.23M | 0.01% |
+4,249
| New | +$1.15M |
|
792
PPG Industries
PPG
$25.2B
| $1.22M | 0.01% |
11,531
+8,122
| +238% | +$782K |
|
793
Polaris
PII
$3.66B
| $1.22M | 0.01% |
+13,167
| New | +$1M |
|
794
Nexstar Media Group
NXST
$5.74B
| $1.22M | 0.01% |
+14,535
| New | +$1.09M |
|
795
Shift4
FOUR
$3.79B
| $1.21M | 0.01% |
+34,150
| New | +$1.25M |
|
796
TripAdvisor
TRIP
$1.19B
| $1.19M | 0.01% |
62,814
-46,281
| -42% | -$884K |
|
797
Eagle Bancorp
EGBN
$857M
| $1.19M | 0.01% |
+36,441
| New | +$1.16M |
|
798
Caleres
CAL
$459M
| $1.19M | 0.01% |
142,028
+113,331
| +395% | +$793K |
|
799
Genesco
GCO
$390M
| $1.18M | 0.01% |
+54,670
| New | +$1.01M |
|
800
Atkore
ATKR
$3.16B
| $1.18M | 0.01% |
+43,242
| New | +$1.07M |
|
Similar funds
Dmitry Balyasny's Q2 2020 Portfolio in Review
As of Q2 2020, Dmitry Balyasny held 1,665 positions worth $11.5B, up 37% from $8.43B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Dmitry Balyasny deployed $1.48B of net new capital in Q2 2020, opening 559 new positions and adding to 260 existing holdings. Its largest new stake was Charles Schwab: 2,556,974 shares worth $86.3M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $96.4M trimmed.
- Dmitry Balyasny's largest Q2 2020 buy was Charles Schwab: 2,556,974 shares worth $86.3M.
- Dmitry Balyasny added most to Fiserv Inc in Q2 2020, an estimated $74.8M increase.
- Dmitry Balyasny's biggest Q2 2020 reduction was Lowe's Companies, cutting an estimated $96.4M.
- Dmitry Balyasny fully exited Allergan plc in Q2 2020, selling an estimated $92.4M.
- Dmitry Balyasny's ten largest holdings make up 9.4% of its $11.5B portfolio in Q2 2020.
- Dmitry Balyasny opened 559 new positions and closed 589 in Q2 2020.
- Dmitry Balyasny's portfolio value rose 37% quarter-over-quarter to $11.5B.
Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.